Is Agilent Technologies, Inc. FDA approved?

Agilent Technologies, Inc. holds 2 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Agilent Technologies, Inc.'s drugs manufactured?

The FDA register lists Boulder, CO; Frederick, CO. Registered operations: analytical testing, active ingredient (API) manufacture.

What drugs does Agilent Technologies, Inc. make?

8 products are listed under Agilent Technologies, Inc. in the openFDA NDC Directory, most often as powder; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Agilent Technologies, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 2
Active NDC listings: 8
Labeller names: 2
Live patents: 0
Countries: 1
Base: United States

Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture2

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Agilent Technologies, Inc.	5555 Airport Blvd, Boulder, Colorado (CO) 80301, United States (USA)	Analytical testing, Active ingredient (API) manufacture	3007057070025478403
Agilent Technologies, Inc.	7051 Eagle Boulevard, Frederick, Colorado (CO) 80504-5875, United States (USA)	Analytical testing, Active ingredient (API) manufacture	3014531850108757257

Catalogue

Drug listings by form and route

8 active NDC listings: 8 bulk ingredient. By marketing category: BULK INGREDIENT 8.

Dosage form	NDCs
powder	6
injection	2

Route	NDCs

Labeller name on the listing	NDCs
agilent technologies inc.	7
agilent technologies, inc.	1

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Plozasiran	injection	70596-1007BULK INGREDIENT
-	Plozisiran	injection	70596-1006BULK INGREDIENT
-	avacincaptad pegol	powder	70596-1005BULK INGREDIENT
-	givosiran sodium	powder	70596-1001BULK INGREDIENT
-	inclisiran sodium	powder	70596-1002BULK INGREDIENT
-	lumasiran sodium	powder	70596-1003BULK INGREDIENT
-	patisiran sodium	powder	70596-1000BULK INGREDIENT
-	vutrisiran sodium	powder	70596-1004BULK INGREDIENT

Neighbours

Registered in the same town

Compare

Comparable companies in United States

Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
PureTek Corporation2 sites · 178 NDC
Apotheca Company2 sites · 110 NDC
Nivagen Pharmaceuticals LLC2 sites · 106 NDC
KVK-TECH, INC.2 sites · 71 NDC
Samsung Biologics Co., Ltd.2 sites · 57 NDC
Veranova, L.P.2 sites · 52 NDC
QUAGEN PHARMACEUTICALS LLC2 sites · 50 NDC
AmerisourceBergen Drug Corporation2 sites · 47 NDC
Genus Lifesciences Inc.2 sites · 46 NDC

Enquiry

Common questions

Is Agilent Technologies, Inc. FDA approved?: Agilent Technologies, Inc. holds 2 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Agilent Technologies, Inc.'s drugs manufactured?: The FDA register lists Boulder, CO; Frederick, CO. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Agilent Technologies, Inc. make?: 8 products are listed under Agilent Technologies, Inc. in the openFDA NDC Directory, most often as powder; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.